论文部分内容阅读
目的:研究并分析治疗重症急性胰腺炎并发全身炎症反应综合征患者时使用乌司他丁的治疗效果。方法:收集重症急性胰腺炎并发全身炎症反应综合征患者共83例,根据随机、单盲、平行对照设计原则分为40例对照组和43例观察组,对照组患者接受常规治疗,观察组在此基础上联合使用乌司他丁,将两组患者的并发症发生率、器官衰竭发生率以及平均住院时间进行观察和对比结果:观察组患者的并发症发生率、器官衰竭发生率明显低于对照组,观察组患者的平均住院时间显著短于对照组患者(P均<0.05)。结论:在重症急性胰腺炎并发全身炎症反应综合征患者的治疗过程中,使用乌司他丁能够有效保护患者的重要脏器功能,降低并发症的发生风险,缩短治疗时间,减少患者的负担,值得推广应用。
Objective: To study and analyze the treatment effect of ulinastatin in patients with severe acute pancreatitis complicated by systemic inflammatory response syndrome. Methods: A total of 83 patients with severe acute pancreatitis complicated by systemic inflammatory response syndrome were divided into 40 control groups and 43 observation groups according to the randomized, single-blind and parallel control design principles. Patients in the control group received conventional therapy. Based on the combination of ulinastatin, the incidence of complications, the incidence of organ failure and the average length of stay in both groups were observed and compared. The incidence of complications and organ failure in the observation group were significantly lower than that in the observation group The average length of stay of patients in the control group and observation group was significantly shorter than that in the control group (all P <0.05). Conclusion: In patients with severe acute pancreatitis complicated by systemic inflammatory response syndrome treatment, the use of ulinastatin can effectively protect the vital organs of patients, reduce the risk of complications, shorten the treatment time, reduce the burden on patients, Worth promoting application.